These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 37747290)

  • 1. Computed tomography defined femoral artery plaque composition predicts vascular complications during transcatheter aortic valve implantation.
    Carande EJ; Salim TS; Chase A; Sekar B; Aldalati O; Hailan A; Khurana A; Smith D; Obaid DR
    Br J Radiol; 2023 Dec; 96(1152):20230296. PubMed ID: 37747290
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of suture mediated femoral access site closure with the Prostar XL compared to the ProGlide system on outcome in transfemoral aortic valve implantation.
    Seeger J; Gonska B; Rodewald C; Rottbauer W; Wöhrle J
    Int J Cardiol; 2016 Nov; 223():564-567. PubMed ID: 27561160
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ultrasound-guided deployment of ProGlide™ device in transfemoral transcatheter aortic valve implantation and risk reduction of vascular complications: A propensity-matched cohort study.
    Ross DS; Nogic J; Cong H; Nuzzi V; Thanikachalam P; Veenuraju S; Gruner-Hegge N; Anwar M; O'Sullivan M; Costopoulos C; Davies WR; Costanzo P
    Catheter Cardiovasc Interv; 2024 Apr; 103(5):771-781. PubMed ID: 38451155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Computed tomography derived anatomical predictors of vascular access complications following transfemoral transcatheter aortic valve implantation: A systematic review.
    Androshchuk V; Chehab O; Prendergast B; Rajani R; Patterson T; Redwood S
    Catheter Cardiovasc Interv; 2024 Jan; 103(1):169-185. PubMed ID: 37994240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Minimalistic Approach for Transcatheter Aortic Valve Implantation (TAVI): Open Vascular Vs. Fully Percutaneous Approach.
    Kedev S; Zafirovska B; Srbinovska-Kostovska E; Antov S; Nikolic A; Dzemali O; Bunc M
    Pril (Makedon Akad Nauk Umet Odd Med Nauki); 2019 Oct; 40(2):5-14. PubMed ID: 31605589
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative data of single versus double proglide vascular preclose technique after percutaneous transfemoral transcatheter aortic valve implantation from the optimized catheter valvular intervention (OCEAN-TAVI) japanese multicenter registry.
    Kodama A; Yamamoto M; Shimura T; Kagase A; Koyama Y; Tada N; Takagi K; Araki M; Yamanaka F; Shirai S; Watanabe Y; Hayashida K
    Catheter Cardiovasc Interv; 2017 Sep; 90(3):E55-E62. PubMed ID: 27785881
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Manta versus Perclose ProGlide vascular closure device after transcatheter aortic valve implantation: Initial experience from a large European center.
    Dumpies O; Kitamura M; Majunke N; Hartung P; Haag A; Wilde J; Desch S; Sandri M; Crusius L; Noack T; Kiefer P; Leontyev S; Borger M; Thiele H; Holzhey D; Abdel-Wahab M
    Cardiovasc Revasc Med; 2022 Apr; 37():34-40. PubMed ID: 34257057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of femoral artery puncture using digital subtraction angiography and road mapping on vascular and bleeding complications after transfemoral transcatheter aortic valve implantation.
    El-Mawardy M; Schwarz B; Landt M; Sulimov D; Kebernik J; Allali A; Becker B; Toelg R; Richardt G; Abdel-Wahab M
    EuroIntervention; 2017 Jan; 12(13):1667-1673. PubMed ID: 28106001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Percutaneous plug-based vascular closure device in 1000 consecutive transfemoral transcatheter aortic valve implantations.
    Kastengren M; Settergren M; Rück A; Feldt K; Saleh N; Linder R; Verouhis D; Meduri CU; Bager J; Dalén M
    Int J Cardiol; 2022 Jul; 359():7-13. PubMed ID: 35427700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vascular Complications Among Patients Undergoing Trans-femoral Transcatheter Aortic Valve Implantation: Prostar
    Marcusohn E; Qasum M; Epstein D; Solomonica A; Orbach A; Musallam A; Kerner A; Feld Y
    Angiology; 2022 Aug; 73(7):635-642. PubMed ID: 35147041
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of MANTA vs ProGlide Vascular Closure Device and 30-Day Outcomes in Transfemoral Transcatheter Aortic Valve Implantation.
    Eftychiou C; Eteocleous N; Mitsis A; Zittis I; Papadopoulos K; Petrou A; Adamou M; Kounnos C; Bekos C; Avraamides P
    Tex Heart Inst J; 2022 Sep; 49(5):. PubMed ID: 36269884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MANTA versus ProGlide vascular closure devices in transfemoral transcatheter aortic valve implantation.
    Biancari F; Romppanen H; Savontaus M; Siljander A; Mäkikallio T; Piira OP; Piuhola J; Vilkki V; Ylitalo A; Vasankari T; Airaksinen JKE; Niemelä M
    Int J Cardiol; 2018 Jul; 263():29-31. PubMed ID: 29681408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiographic Analysis of Vascular Integrity After Percutaneous Closure Using Prostar XL Device During Transcatheter Aortic Valve Implantation.
    Lareyre F; Raffort J; Dommerc C; Benhammamia M; Bourlon F; Habib Y; Mialhe C
    Vasc Endovascular Surg; 2017 Jul; 51(5):282-287. PubMed ID: 28474978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictability and Outcome of Vascular Complications after Transfemoral Transcatheter Aortic Valve Implantation.
    Uguz E; Gokcimen M; Ali S; Alsancak Y; Bastug S; Ahmet Kasapkara H; Canyigit M; Hıdıroglu M; Sener E
    J Heart Valve Dis; 2016 Mar; 25(2):173-181. PubMed ID: 27989061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vascular complications with a plug-based vascular closure device after transcatheter aortic valve replacement: Predictors and bail-outs.
    van Wiechen MP; Kroon H; Hokken TW; Ooms JF; de Ronde-Tillmans MJ; Daemen J; de Jaegere PP; Van Mieghem NM
    Catheter Cardiovasc Interv; 2021 Nov; 98(5):E737-E745. PubMed ID: 33533544
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Computed Tomographic Angiography-Derived Risk Factors for Vascular Complications in Percutaneous Transfemoral Transcatheter Aortic Valve Implantation.
    Urbach J; Hou CR; Lesser JR; Stanberry LI; Garberich RF; Caye D; Sorajja P; Gössl M
    Am J Cardiol; 2019 Jul; 124(1):98-104. PubMed ID: 31029410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the MANTA Vascular Closure Device in Transfemoral TAVI.
    Kmiec L; Zerdzitzki M; Schmid C; Debl K; Sossalla S; Hilker M; Holzamer A
    Thorac Cardiovasc Surg; 2023 Mar; 71(2):84-93. PubMed ID: 34176110
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of a Pure Plug-Based Versus a Primary Suture-Based Vascular Closure Device Strategy for Transfemoral Transcatheter Aortic Valve Replacement: The CHOICE-CLOSURE Randomized Clinical Trial.
    Abdel-Wahab M; Hartung P; Dumpies O; Obradovic D; Wilde J; Majunke N; Boekstegers P; Müller R; Seyfarth M; Vorpahl M; Kiefer P; Noack T; Leontyev S; Sandri M; Rotta Detto Loria J; Kitamura M; Borger MA; Funkat AK; Hohenstein S; Desch S; Holzhey D; Thiele H;
    Circulation; 2022 Jan; 145(3):170-183. PubMed ID: 34738828
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The novel echo-guided ProGlide technique during percutaneous transfemoral transcatheter aortic valve implantation.
    Honda Y; Araki M; Yamawaki M; Tokuda T; Tsutumi M; Mori S; Sakamoto Y; Kobayashi N; Hirano K; Ito Y
    J Interv Cardiol; 2018 Apr; 31(2):216-222. PubMed ID: 29193337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Access site related vascular complications with third generation transcatheter heart valve systems.
    Ruge H; Burri M; Erlebach M; Lange R
    Catheter Cardiovasc Interv; 2021 Feb; 97(2):325-332. PubMed ID: 32588968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.